Insights Into Statin Intolerance.
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota.
Stephen
S
Kopecky
Women's Preventive Cardiology Center, Raton Regional Hospital, Boca Raton, Florida.
Seth
S
Baum
Global Center for Scientific Affairs, Merck Research Labs, Kenilworth, New Jersey.
JoAnne M
JM
Foody
Jacksonville Center for Clinical Research, Jacksonville, Florida.
Michael
M
Koren
National Clinical Research, Inc., Richmond, Virginia.
James
J
McKenney
Emory Heart Disease Prevention Center, Emory University, Atlanta, Georgia.
Laurence
L
Sperling
Heart Disease Prevention Program, University of California Irvine, Irvine, California.
Nathan D
ND
Wong
D000465:Algorithms; D000818:Animals; D015415:Biomarkers / Q000097:blood; D003402:Creatine Kinase / Q000097:blood; D019091:Critical Pathways; D057915:Drug Substitution; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D018482:Muscle, Skeletal / Q000187:drug effects* / Q000201:enzymology / Q000503:physiopathology; D063806:Myalgia / Q000139:chemically induced* / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D017288:Pain Threshold / Q000187:drug effects; D011237:Predictive Value of Tests; D011379:Prognosis; D012206:Rhabdomyolysis / Q000139:chemically induced* / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D012307:Risk Factors
D015415:Biomarkers; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D003402:Creatine Kinase